Publication

Building laboratory capacity to detect and characterize pathogens of public and global health security concern in Kenya

Downloadable Content

Persistent URL
Last modified
  • 05/23/2025
Type of Material
Authors
    Elizabeth Hunsperger, Centers for Disease Control and PreventionBonventure Juma, Centers for Disease Control and PreventionClayton Onyango, Centers for Disease Control and PreventionJohn B. Ochieng, Kenya Medical Research InstituteVictor Omballa, Kenya Medical Research InstituteBarry Fields, Emory UniversityM. Kariuki Njenga, Washington State UniversityJane Mwangi, Centers for Disease Control and PreventionGodfrey Bigogo, Kenya Medical Research InstituteRichard Omore, Kenya Medical Research InstituteNancy Otieno, Kenya Medical Research InstituteSandra S. Chaves, Centers for Disease Control and PreventionPeninah Munyua, Centers for Disease Control and PreventionDaniel Macharia Njau, Centers for Disease Control and PreventionJennifer Verani, Emory UniversitySara Lowther, Centers for Disease Control and PreventionRobert F Breiman, Emory UniversityJoel M Montgomery, Centers for Disease Control and PreventionKevin M. De Cock, Centers for Disease Control and PreventionMarc-Alain Widdowson, Centers for Disease Control and Prevention
Language
  • English
Date
  • 2019-05-10
Publisher
  • BMC (part of Springer Nature)
Publication Version
Copyright Statement
  • © 2019 The Author(s).
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 1471-2458
Volume
  • 19
Grant/Funding Information
  • Research and publication costs are funded by Centers for Disease Control and Prevention, Centers for Global Health, Division of Global Health Protection, Epidemiology, Informatics, Surveillance and Laboratory Branch.
Abstract
  • Since 1979, multiple CDC Kenya programs have supported the development of diagnostic expertise and laboratory capacity in Kenya. In 2004, CDC's Global Disease Detection (GDD) program within the Division of Global Health Protection in Kenya (DGHP-Kenya) initiated close collaboration with Kenya Medical Research Institute (KEMRI) and developed a laboratory partnership called the Diagnostic and Laboratory Systems Program (DLSP). DLSP built onto previous efforts by malaria, human immunodeficiency virus (HIV) and tuberculosis (TB) programs and supported the expansion of the diagnostic expertise and capacity in KEMRI and the Ministry of Health. First, DLSP developed laboratory capacity for surveillance of diarrheal, respiratory, zoonotic and febrile illnesses to understand the etiology burden of these common illnesses and support evidenced-based decisions on vaccine introductions and recommendations in Kenya. Second, we have evaluated and implemented new diagnostic technologies such as TaqMan Array Cards (TAC) to detect emerging or reemerging pathogens and have recently added a next generation sequencer (NGS). Third, DLSP provided rapid laboratory diagnostic support for outbreak investigation to Kenya and regional countries. Fourth, DLSP has been assisting the Kenya National Public Health laboratory-National Influenza Center and microbiology reference laboratory to obtain World Health Organization (WHO) certification and ISO15189 accreditation respectively. Fifth, we have supported biosafety and biosecurity curriculum development to help Kenyan laboratories safely and appropriately manage infectious pathogens. These achievements, highlight how in collaboration with existing CDC programs working on HIV, tuberculosis and malaria, the Global Health Security Agenda can have significantly improve public health in Kenya and the region. Moreover, Kenya provides an example as to how laboratory science can help countries detect and control of infectious disease outbreaks and other public health threats more rapidly, thus enhancing global health security.
Author Notes
Keywords
Research Categories
  • Health Sciences, Public Health

Tools

Relations

In Collection:

Items